Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIVIUM LTD Director's Dealing 2025

Aug 4, 2025

65239_rns_2025-08-04_3181e106-260d-49ce-9c21-2ca56d0ae465.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11

Name of entity Livium Ltd Name of entity Livium Ltd
ABN 29 126 129 413
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for thepurposes of section 205G of the Corporations Act.
Name of Director Simon Linge
Date of last notice 7 March 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

isclosed in thispart.
Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Sagacious Enterprises Pty Ltd <The Linge FamilyA/C> (Mr Simon Linge is a director of SagaciousEnterprises Pty Ltd)Linge Nominees Pty Ltd <3RD Phase Legacy FundA/C> (Mr Simon Linge is a director of LingeNominees Pty Ltd)
Date of change 4 August 2025
No. of securities held prior to change Direct:6,000,000PerformanceRightsexpiring31December 202636,000,000 Performance Rights expiring 31December 2028Indirect:Sagacious Enterprises Pty Ltd <The Linge FamilyA/C>:2,272,727 Ordinary SharesLinge Nominees Pty Ltd <3RD Phase Legacy FundA/C>:909,091 Ordinary Shares
Class (a) Ordinary Shares(b) Performance Rights expiring 31 December2026
Number acquired (a) 6,000,000
Number disposed (b) 6,000,000
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Conversion of performance rights for non-cash
Note: If consideration is non-cash, provide details and estimated valuation consideration. Estimated value of shares issued
based on current share price is $0.01/share.
No. of securities held after change Direct:
6,000,000 Ordinary Shares
36,000,000 Performance Rights expiring 31
December 2028
Indirect:
Sagacious Enterprises Pty Ltd <The Linge Family
A/C>:
2,272,727 Ordinary Shares
Linge Nominees Pty Ltd <3RD Phase Legacy Fund
A/C>:
909,091 Ordinary Shares
Nature of change Shares issued upon conversion of Performance
Example: on-market trade, off-market trade, exercise of options, issue of Rights.
securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

sclosed in thispart.
Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
**Date of change ** N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a
contract in relation to which the
interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash,
provide details and an estimated
valuation
**Interest after change ** N/A

Part 3 –[+] Closed period

art 3 –+Closedperiod
Were the interests in the securities or contracts detailed above traded during a+closed No
period whereprior written clearance was required?
If so, wasprior written clearanceprovided to allow the trade toproceed during thisperiod? N/A
Ifprior written clearance wasprovided, on what date was thisprovided? N/A

Released: 5 August 2025

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2